Discover
SION
Sionna Therapeutics, Inc.
47.65
1 x 46.71
1 x 54.80
bid
ask
+
0.44
0.93%
09:31 AM
timesize
| Ytd | 15.82% | |
| 1y | 150.53% |
46.79
day range
47.24
16.38
52 week range
51.56
| Open | 47.16 | Prev Close | 47.21 | Low | 46.79 | High | 47.24 | Mkt Cap | 2.13B |
| Vol | 4.71K | Avg Vol | 456.64K | EPS | -1.93 | P/E | -24.46 | Forward P/E | -16.16 |
| Beta | 1.33 | Short Ratio | 12.17 | Inst. Own | 100.03% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 08-10 | 50-d Avg | 41.04 | 200-d Avg | 39.16 | 1yr Est | 51.60 |
| Income Statement | |||
| Operating Expenses | 29.60M | ||
| Research and Development Expense | 18.96M | ||
| Selling, General and Administrative Expense | 10.64M | ||
| Operating Income | -29.60M | ||
| Net Income | -26.78M | ||
| Net Income Common Stock | -26.78M | ||
| Net Income Common Stock (USD) | -26.78M | ||
| Consolidated Income | -26.78M | ||
| Earnings per Basic Share | -0.60 | ||
| Earnings per Basic Share (USD) | -0.60 | ||
| Earnings per Diluted Share | -0.60 | ||
| Earning Before Interest & Taxes (EBIT) | -26.78M | ||
| Earning Before Interest & Taxes (USD) | -26.78M | ||
| Weighted Average Shares | 44.92M | ||
| Weighted Average Shares Diluted | 44.92M | ||
| Balance Sheet | |||
| Cash and Equivalents | 64.29M | ||
| Cash and Equivalents (USD) | 64.29M | ||
| Investments | 226.61M | ||
| Investments Current | 152.83M | ||
| Investments Non-Current | 73.78M | ||
| Current Assets | 220.96M | ||
| Property, Plant & Equipment Net | 8.75M | ||
| Total Assets | 305.04M | ||
| Debt Current | 1.32M | ||
| Total Debt | 8.38M | ||
| Current Liabilities | 9.78M | ||
| Debt Non-Current | 7.06M | ||
| Total Liabilities | 16.83M | ||
| Accumulated Retained Earnings (Deficit) | -283.13M | ||
| Accumulated Other Comprehensive Income | -84.00K | ||
| Shareholders Equity | 288.21M | ||
| Shareholders Equity (USD) | 288.21M | ||
| Assets Non-Current | 84.08M | ||
| Total Debt (USD) | 8.38M | ||
| Liabilities Non-Current | 7.06M | ||
| Trade and Non-Trade Payables | 2.11M | ||
| Cash Flow | |||
| Depreciation, Amortization & Accretion | 643.00K | ||
| Net Cash Flow from Financing | 1.89M | ||
| Net Cash Flow / Change in Cash & Cash Equivalents | 4.87M | ||
| Issuance (Purchase) of Equity Shares | 2.21M | ||
| Net Cash Flow from Investing | 24.82M | ||
| Net Cash Flow - Investment Acquisitions and Disposals | 24.82M | ||
| Net Cash Flow from Operations | -21.84M | ||
| Share Based Compensation | 6.55M | ||